2021 MIPS Measure #014: Age-Related Macular Degeneration (AMD): Dilated Macular Examination 

Measure Type High Priority Measure? Collection Type(s)
Process no Medicare Part B Claims, MIPS CQM

 

Measure Description

Percentage of patients aged 50 years and older with a diagnosis of age-related macular degeneration (AMD) who had a dilated macular examination performed which included documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage AND the level of macular degeneration severity during one or more office visits within the 12 month performance period